Literature DB >> 10523850

Function for p300 and not CBP in the apoptotic response to DNA damage.

Z M Yuan1, Y Huang, T Ishiko, S Nakada, T Utsugisawa, H Shioya, Y Utsugisawa, Y Shi, R Weichselbaum, D Kufe.   

Abstract

The cellular response to ionizing radiation (IR) includes the induction of apoptosis. The p300/CBP proteins possess histone acetyltransferase activity and function as transcriptional coactivators of p53. We have prepared cells deficient in p300 or CBP to define the roles of these proteins in the cellular response to DNA damage. The present results demonstrate that p300, but not CBP, contributes to IR sensitivity of cells. The results also demonstrate that IR-induced apoptosis is impaired in the p300-, but not CBP-, deficient cells. These findings indicate that p300 functions in the apoptotic response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523850     DOI: 10.1038/sj.onc.1202930

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

Review 1.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 2.  Biological role of p300 in cardiac myocytes.

Authors:  Tetsuhiko Yanazume; Tatsuya Morimoto; Hiromichi Wada; Teruhisa Kawamura; Koji Hasegawa
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

3.  Expression of an E1A/E7 chimeric protein sensitizes tumor cells to killing by activated macrophages but not NK cells.

Authors:  Tanya A Miura; Han Li; Kristin Morris; Sharon Ryan; Kristine Hembre; James L Cook; John M Routes
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.

Authors:  David Dornan; Harumi Shimizu; Lindsay Burch; Amanda J Smith; Ted R Hupp
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

5.  Identification of a novel p300-specific-associating protein, PRS1 (phosphoribosylpyrophosphate synthetase subunit 1).

Authors:  Atsushi Kaida; Yasuo Ariumi; Keiko Baba; Masami Matsubae; Toshifumi Takao; Kunitada Shimotohno
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

6.  Epigenetic mechanisms of Rubinstein-Taybi syndrome.

Authors:  Elizabeth Park; Yunha Kim; Hyun Ryu; Neil W Kowall; Junghee Lee; Hoon Ryu
Journal:  Neuromolecular Med       Date:  2014-01-01       Impact factor: 3.843

7.  BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.

Authors:  Leandro C Cerchietti; Katerina Hatzi; Eloisi Caldas-Lopes; Shao Ning Yang; Maria E Figueroa; Ryan D Morin; Martin Hirst; Lourdes Mendez; Rita Shaknovich; Philip A Cole; Kapil Bhalla; Randy D Gascoyne; Marco Marra; Gabriela Chiosis; Ari Melnick
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

8.  Quantitative analysis of CBP- and P300-induced histone acetylations in vivo using native chromatin.

Authors:  Kirk J McManus; Michael J Hendzel
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

9.  Phylogenetic origin of LI-cadherin revealed by protein and gene structure analysis.

Authors:  R Jung; M W Wendeler; M Danevad; H Himmelbauer; R Gessner
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

10.  The role of p300 histone acetyltransferase in UV-induced histone modifications and MMP-1 gene transcription.

Authors:  Min-Kyoung Kim; Jung-Min Shin; Hee Chul Eun; Jin Ho Chung
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.